Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia.

[1]  W. Mack,et al.  The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Y. Marcel,et al.  Role of Lp A-I and Lp A-I/A-II in cholesteryl ester transfer protein-mediated neutral lipid transfer. Studies in normal subjects and in hypertriglyceridemic patients before and after fenofibrate therapy. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[3]  L. Coupal,et al.  Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work? , 1995, JAMA.

[4]  Vesa Manninen,et al.  Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study: Implications for Treatment , 1992, Circulation.

[5]  D. Shapiro,et al.  Long-term safety and efficacy profile of simvastatin. , 1991, The American journal of cardiology.

[6]  C. Shear,et al.  Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia. , 1991, The American journal of medicine.

[7]  S. Ringel,et al.  Cholesterol‐lowering agent myopathy (CLAM) , 1991, Neurology.

[8]  J. Deslypere,et al.  Rhabdomyolysis and simvastatin. , 1991, Annals of internal medicine.

[9]  T. Gross,et al.  Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. , 1990, JAMA.

[10]  A. Kogan,et al.  Lovastatin-induced acute rhabdomyolysis. , 1990, Postgraduate medical journal.

[11]  K. K. Larson,et al.  Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy. , 1990, Annals of internal medicine.

[12]  J. Goldman,et al.  The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis. , 1989, Arthritis and rheumatism.

[13]  D. Illingworth,et al.  Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia. , 1989, Circulation.

[14]  C. Fuchs,et al.  Lovastatin and rhabdomyolysis. , 1988, Annals of internal medicine.

[15]  P. Reaven,et al.  Lovastatin, nicotinic acid, and rhabdomyolysis. , 1988, Annals of internal medicine.

[16]  S. Grundy,et al.  Combination drug therapy for familial combined hyperlipidemia. , 1988, Annals of internal medicine.

[17]  S. Grundy,et al.  Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation. , 1988, The New England journal of medicine.

[18]  B. Lewis,et al.  Kinetic bases of the primar hperlipidaemias: studies of apolipoprotein B turnover in geneticall defined subjects , 1980 .

[19]  A. Chait,et al.  Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia , 1980, European journal of clinical investigation.

[20]  I. Benzie.  An evaluation of a routine assay of serum high-density lipoprotein cholesterol using dextran sulphate and magnesium chloride. , 1979, Medical laboratory sciences.

[21]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[22]  J. Shepherd.  Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety. , 1995, European heart journal.

[23]  B. Angelin,et al.  Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia. , 1993, The American journal of medicine.

[24]  U. de Girolami,et al.  Lovastatin/gemfibrozil myopathy: a clinical, histochemical, and ultrastructural study. , 1992, European neurology.

[25]  R. Chichmanian,et al.  [Drug-induced rhabdomyolysis]. , 1991, Annales de medecine interne.

[26]  R. Krauss,et al.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.